← FDA Drug Approvals (Drugs@FDA)
LOTEPREDNOL ETABONATE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2023-11-29
Drug application
- FDA Application #
ANDA213956- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- LOTEPREDNOL ETABONATE
- Generic name
- Loteprednol Etabonate
- Active ingredients
- LOTEPREDNOL ETABONATE
- Dosage form
- GEL
- Route
- OPHTHALMIC
- Marketing status
- Discontinued
- Sponsor
- HIKMA
- First approval
- 2023-11-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown